Failure to demonstrate complement activation during bronchial challenge test.
In order to demonstrate a possible complement activation during early bronchospastic reaction in asthma, we have measured plasmatic C3d (a split product of C3) and the C3d/C3 index, both of which are sensitive indices of complement activation. Twenty-nine allergenic bronchial challenge tests were accomplished, with an absence of response in six cases, an early reaction in sixteen cases and a dual reaction in seven cases. Changes in plasmatic C3d or C3d/C3 five min after an early reaction, or five min after the last dose of allergen (in the six cases without bronchial response) were insignificant. However, complement activation in the lungs during asthmatic reaction cannot be completely excluded without studies using the bronchoalveolar technique.
Michel
O
O
Pulmonary Division (Development of Internal Medicine), Saint-Pierre University Hospital, Brussels, Belgium.
Duchateau
J
J
Sergysels
R
R
D000293:Adolescent; D000328:Adult; D000403:Airway Resistance; D000485:Allergens; D001249:Asthma / Q000276:immunology* / Q000503:physiopathology; D001985:Bronchial Provocation Tests; D003167:Complement Activation; D003176:Complement C3 / Q000032:analysis; D015933:Complement C3d; D003181:Complement C4 / Q000032:analysis; D005260:Female; D005541:Forced Expiratory Volume; D006801:Humans; D008297:Male; D008875:Middle Aged
D000485:Allergens; D003176:Complement C3; D003181:Complement C4; D015933:Complement C3d